The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
Attention Score in Context
Title |
Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: From the Beginning to the Latest Developments
|
---|---|
Published in |
Frontiers in oncology, July 2022
|
DOI | 10.3389/fonc.2022.912699 |
Pubmed ID | |
Authors |
Giandomenico Roviello, Martina Catalano, Raffaella Santi, Matteo Santoni, Ilaria Camilla Galli, Andrea Amorosi, Wojciech Polom, Ugo De Giorgi, Gabriella Nesi |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 5 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 60% |
Scientists | 2 | 40% |
Mendeley readers
The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 20 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Doctoral Student | 2 | 10% |
Student > Master | 2 | 10% |
Student > Bachelor | 1 | 5% |
Researcher | 1 | 5% |
Professor > Associate Professor | 1 | 5% |
Other | 1 | 5% |
Unknown | 12 | 60% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 3 | 15% |
Neuroscience | 2 | 10% |
Immunology and Microbiology | 1 | 5% |
Sports and Recreations | 1 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 5% |
Other | 0 | 0% |
Unknown | 12 | 60% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 March 2024.
All research outputs
#15,218,027
of 26,314,361 outputs
Outputs from Frontiers in oncology
#4,068
of 22,971 outputs
Outputs of similar age
#182,546
of 439,149 outputs
Outputs of similar age from Frontiers in oncology
#272
of 1,770 outputs
Altmetric has tracked 26,314,361 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,971 research outputs from this source. They receive a mean Attention Score of 3.2. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 439,149 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.
We're also able to compare this research output to 1,770 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.